FDA Inspection 1099590 — Mylan Pharmaceuticals Inc

Mylan Pharmaceuticals Inc — FEI 1110315

The FDA completed an inspection of Mylan Pharmaceuticals Inc on August 15, 2019 in Morgantown, WV. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 15, 2019
Fiscal Year
2019
Product Type
Devices
Project Area
Compliance: Devices
Location
Morgantown, WV (United States)

Citations

IDCFRDescription
316821 CFR 820.198(a)Complaints